Skip to main content

Table 1 Demographics and clinicopathologic characteristics of 86 patients

From: Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review

Variables

Caudate lobe metastases ( n= 45)

Number of caudate lobe metastases ( n= 41)

P value

Mean age (range)

54.8 (29 to 85)

53.5 (28 to 75)

0.85

Gender M:F

17:28

20:21

0.29

Comorbidities

14 (31%)

18 (43.9%)

0.45

Carcinoid syndrome pre-TACE

38 (84.4%)

35 (85.4%)

.92

Primary resected

17 (38%)

27 (65.8%)

<0.03

Pancreas primary

10 (22%)

10 (24.4%)

0.096

Tumor non-functional at presentation

30 (65.9%)

20 (48.9%)

0.085

Tumor grade

  

0.795

1

36 (80%)

33 (80.5%)

 

2

4 (8.9%)

4 (9.8%)

 

3

2 (4.4%)

2 (4.9%)

 

Median pre-TACE pancreastatin level pg/ml (range)

12,856 (84 to 56,200)

5,985 (104 to 46,400)

<0.03

Median number of liver segments with metastases (range)

8 (5 to 8)

5 (2 to 8)

<0.05

Median (range) percentage of metastatic burden to liver

71.4% (30 to 95)

48.7% (5 to 95)

<0.01

Presence of extrahepatic disease

32 (71%)

22 (54%)

0.24

Presence of lymph node metastases

9 (22%)

7 (15.6%)

0.489